SYNACT PHARMA ApS: Financial statements 2024
CVR: 34459975
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
SYNACT PHARMA ApS (CVR 34459975) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -26,274,866 and a net result of DKK -30,477,376 compared with DKK -65,408,926 the year before. Equity in the 2024 report amounted to DKK 25,108,586. The solvency ratio was 66.4%. The company had 4 employees in the financial year.
- Gross Profit
- DKK -26,274,866
- Profit/Loss
- DKK -30,477,376
- Equity
- DKK 25,108,586
- Total Assets
- DKK 37,792,081
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -26.3 mio. | -30.5 mio. | 25.1 mio. | 4 |
| 2023 | - | -63.4 mio. | -65.4 mio. | 15.6 mio. | 3 |
| 2022 | - | -47 mio. | -49.8 mio. | 34 mio. | 3 |
| 2021 | - | -43.4 mio. | -41.2 mio. | 6.6 mio. | 2 |
| 2020 | - | -16.7 mio. | -14 mio. | 11.4 mio. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
SYNACT PHARMA ApS has published its annual report for 2023. Gross profit came to DKK -63,448,353, and the net result was DKK -65,408,926.
As of March 20, 2024, Jeppe Øvli Øvlesen is registered as adm. dir. of SYNACT PHARMA ApS.
As of March 20, 2024, Torbjørn Bjerke has stepped down as adm. dir. of SYNACT PHARMA ApS.
About SYNACT PHARMA ApS
SYNACT PHARMA ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SYNACTION PHARMA ApS. The management consists of Jeppe Øvli Øvlesen, Thomas Boesen and Ann Kristin Brøgger Led. The company is owned by SynAct Pharma AB. In 2025, the company reported a gross profit of DKK -53,194,923 and a net result of DKK -59,812,937 compared with DKK -30,477,376 the year before. Equity in the 2025 report amounted to DKK 20,295,649.